Convergent pathways in Parkinson’s disease

被引:0
|
作者
Marta Cherubini
Richard Wade-Martins
机构
[1] University of Oxford,Oxford Parkinson’s Disease Centre, Department of Physiology, Anatomy and Genetics, Le Gros Clark Building
来源
Cell and Tissue Research | 2018年 / 373卷
关键词
Parkinson’s disease; Dopamine neurons; Autophagy; Calcium; Intracellular trafficking;
D O I
暂无
中图分类号
学科分类号
摘要
Preferential degeneration of dopamine neurons (DAn) in the midbrain represents the principal hallmark of Parkinson’s disease (PD). It has been hypothesized that major contributors to DAn vulnerability lie in their unique cellular physiology and architecture, which make them particularly susceptible to stress factors. Here, we report a concise overview of some of the cell mechanisms that may exacerbate DAn sensitivity and loss in PD. In particular, we highlight how defective protein sorting and clearance, endoplasmic reticulum stress, calcium dyshomeostasis and intracellular trafficking converge to contribute synergistically to neuronal dysfunction in PD pathogenesis.
引用
收藏
页码:79 / 90
页数:11
相关论文
共 50 条
  • [21] UNDERSTANDING THE EARLY PATHOLOGICAL PATHWAYS IN PARKINSON'S DISEASE. THE OXFORD PARKINSON'S DISEASE CENTRE
    Hu, M.
    Ponting, C.
    Mackay, C.
    Talbot, K.
    Wade-Martins, R.
    Wood, M.
    Bolam, J. P.
    Ben-Shlomo, Y.
    Ansorge, O.
    James, W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E59 - E59
  • [22] Investigating convergent actions of genes linked to familial Parkinson's disease
    Wolozin, Benjamin
    Saha, Shamol
    Guillily, Maria
    Ferree, Andrew
    Riley, Misha
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 182 - 185
  • [23] Endosomal sorting pathways in the pathogenesis of Parkinson's disease
    Cunningham, Lindsey A.
    Moore, Darren J.
    RECENT ADVANCES IN PARKINSON'S DISEASE, 2020, 252 : 271 - 306
  • [24] Pathways towards an effective immunotherapy for Parkinson's disease
    Hutter-Saunders, Jessica A. L.
    Mosley, Rodney Lee
    Gendelman, Howard E.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (12) : 1703 - 1715
  • [25] Genetic Pathways Involved in the Pathogenesis of Parkinson's Disease
    Skolariki, Konstantina
    Diamantopoulos, Marios
    Vlamos, Panayiotis
    GENEDIS 2020: GENETICS AND NEURODEGENERATIVE DISEASES, 2021, 1339
  • [26] Identifying Diverse Pathways to Dementia in Parkinson's Disease
    Chiraki, Nancy
    Nelvagal, Hemanth
    Curless, Toby
    Brandner, Sebastian
    Fernandez, Eduardo De Pablo
    Morris, Huw
    Hardy, John
    Lim, Yau Mun
    Jaunmuktane, Zane
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2025, 51
  • [27] Brain iron pathways and their relevance to Parkinson's disease
    Berg, D
    Gerlach, M
    Youdim, MBH
    Double, KL
    Zecca, L
    Riederer, P
    Becker, G
    JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) : 225 - 236
  • [28] Neurodegenerative Pathways in Parkinson's Disease: Therapeutic Strategies
    Cardoso, S. M.
    Moreira, P., I
    Agostinho, P.
    Pereira, C.
    Oliveira, C. R.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (04) : 405 - 419
  • [29] Molecular genetic pathways in Parkinson's disease: a review
    Jain, S
    Wood, NW
    Healy, DG
    CLINICAL SCIENCE, 2005, 109 (04) : 355 - 364
  • [30] The interplay between neuroinflammatory pathways and Parkinson's disease
    Eser, Pinar
    Kocabicak, Ersoy
    Bekar, Ahmet
    Temel, Yasin
    EXPERIMENTAL NEUROLOGY, 2024, 372